Overview
Aortic valve sclerosis (AVS) is a condition characterized by thickening of the aortic valve without significant stenosis, often resembling atherosclerotic processes in coronary arteries 13.Diagnosis
Echocardiography: Primary diagnostic tool for detecting AVS 12.
Platelet Indices: Elevated mean platelet volume (MPV) and platelet distribution width (PDW) may indicate increased risk 1.
Tooth Loss: Reduced number of teeth independently associated with AVS 2.
Lipid Profile: Elevated levels of triglyceride-rich lipoproteins and specific apolipoproteins (e.g., apo C(II), apo C(III)) may correlate with AVS 3.Management
No Specific Pharmacological Treatment Mentioned: Current evidence does not specify first-line pharmacological treatments for AVS 123.
Lifestyle Modifications: Recommended to manage cardiovascular risk factors such as hypertension, hyperlipidemia, and diabetes 123.
Monitoring: Regular echocardiographic follow-up to assess progression 1.Special Populations
Pregnancy and Lactation: Grossly visible aortic sclerosis appears more severely in multiparous rats during gestation and lactation, suggesting potential increased risk in human contexts 4.
Elderly: Older age is a risk factor for AVS 23.
Comorbidities: History of myocardial infarction, elevated BMI, pulse pressure, and elevated plasma fibrinogen and lipoprotein(a) levels are associated with increased risk 2.Key Recommendations
Echocardiography for Diagnosis: Use echocardiography to diagnose AVS 12. (Evidence: Moderate)
Monitor Platelet Parameters: Consider elevated MPV and PDW as potential risk indicators for AVS 1. (Evidence: Moderate)
Assess Oral Health: Evaluate tooth loss as an independent risk factor for AVS in clinical assessment 2. (Evidence: Moderate)
Manage Cardiovascular Risk Factors: Implement lifestyle modifications and monitor cardiovascular risk factors in patients with AVS 123. (Evidence: Moderate)
Regular Follow-Up: Schedule regular echocardiographic evaluations to monitor progression of AVS 1. (Evidence: Moderate)References
1 Sucu M, Davutoglu V, Sari I, Ozer O, Aksoy M. Relationship between platelet indices and aortic valve sclerosis. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2010. link
2 Völzke H, Schwahn C, Hummel A, Wolff B, Kleine V, Robinson DM et al.. Tooth loss is independently associated with the risk of acquired aortic valve sclerosis. American heart journal 2005. link
3 Gerber Y, Goldbourt U, Feinberg MS, Segev S, Harats D. Are triglyceride-rich lipoproteins associated with aortic valve sclerosis? A preliminary report. Atherosclerosis 2003. link00292-2)
4 Wexler BC. Appearance of grossly-visible aortic sclerosis in breeder rats: reconfirmation and up-date, 1957-1981. Paroi arterielle 1981. link